Ipledge/Isotretinoin/Accutane

iPledge Program

iPledge is a federal program designed to regulate and monitor patients taking this medication, especially those who may become pregnant. Treatment typically lasts between six to eight consecutive months.

Eligibility:

• Patients with moderate to severe acne.
• Patients who have not responded to first-line treatments.
• Patients who can comply with the program's strict guidelines.

Program Requirements:

• Monthly lab tests and pregnancy screenings.
• Strict adherence to birth control measures.
• Completion of required iPledge education and consent forms.

Key Benefits:

• Provides a structured and safe treatment approach.
• Ensures patient safety through close monitoring.
• Helps achieve long-term acne clearance.

Important Considerations:

• Strict compliance with program guidelines is required.
• Regular follow-up appointments are necessary.
• Failure to comply may result in treatment interruptions.